146 related articles for article (PubMed ID: 37343199)
1. Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
Oosterom N; Gooskens SLM; Renfro LA; Perlman EJ; van den Heuvel-Eibrink MM; Hamilton TE; Green DM; Grundy PE; Daw NC; Geller JI; Dome JS; Fernandez CV; Mullen EA
J Clin Oncol; 2023 Sep; 41(26):4247-4256. PubMed ID: 37343199
[TBL] [Abstract][Full Text] [Related]
2. Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study Group.
Raine J; Bowman A; Wallendszus K; Pritchard J
J Clin Oncol; 1991 Feb; 9(2):268-73. PubMed ID: 1846405
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
[TBL] [Abstract][Full Text] [Related]
6. Treatment of bilateral Wilms' tumor: comparison of initial biopsy and chemotherapy to initial surgical resection in the preservation of renal mass and function.
Shaul DB; Srikanth MM; Ortega JA; Mahour GH
J Pediatr Surg; 1992 Aug; 27(8):1009-14; discussion 1014-5. PubMed ID: 1328585
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study.
Corn BW; Goldwein JW; Evans I; D'Angio GJ
J Clin Oncol; 1992 Aug; 10(8):1305-9. PubMed ID: 1321894
[TBL] [Abstract][Full Text] [Related]
8. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
9. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ
Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
[TBL] [Abstract][Full Text] [Related]
10. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.
Kalapurakal JA; Green DM; Haase G; Anderson JR; Dome JS; Grundy PE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):554-8. PubMed ID: 20457352
[TBL] [Abstract][Full Text] [Related]
12. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.
Kalapurakal JA; Li SM; Breslow NE; Beckwith JB; Macklis R; Thomas PR; D'Angio GJ; Kim T; de Lorimier A; Kelalis P; Shochat S; Ritchey M; Haase G; Hrabovsky E; Otherson HB; Grundy P; Green DM;
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):495-9. PubMed ID: 12957262
[TBL] [Abstract][Full Text] [Related]
13. Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.
Benedetti DJ; Varela CR; Renfro LA; Tornwall B; Dix DB; Ehrlich PF; Glick RD; Kalapurakal J; Perlman E; Gratias E; Seibel NL; Geller JI; Khanna G; Malogolowkin M; Grundy P; Fernandez CV; Dome JS; Mullen EA
Cancer; 2024 Mar; 130(6):947-961. PubMed ID: 37933882
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
[TBL] [Abstract][Full Text] [Related]
15. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D
J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor.
Pachnis A; Pritchard J; Gaze M; Levitt G; Michalski A
Med Pediatr Oncol; 1998 Sep; 31(3):150-2. PubMed ID: 9722896
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
Green DM; Breslow NE; Beckwith JB; Takashima J; Kelalis P; D'Angio GJ
J Clin Oncol; 1993 Jan; 11(1):91-5. PubMed ID: 8380295
[TBL] [Abstract][Full Text] [Related]
18. Acute toxicities associated with radiation in the second National Wilms' Tumor Study.
Thomas PR; Tefft M; D'Angio GJ; Norkool P
J Clin Oncol; 1988 Nov; 6(11):1694-8. PubMed ID: 2846791
[TBL] [Abstract][Full Text] [Related]
19. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.
Green DM; Norkool P; Breslow NE; Finklestein JZ; D'Angio GJ
J Clin Oncol; 1990 Sep; 8(9):1525-30. PubMed ID: 2167951
[TBL] [Abstract][Full Text] [Related]
20. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
